Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives
Aim. To evaluate the efficacy of the antiviral drug riamilovir (trade name – «Triazavirin®») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups. Materials and methods. The study involved 386 individuals aged 18–...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe / Cruthaithe: |
"Consilium Medicum" Publishing house
2024-12-01
|
| Sraith: | Терапевтический архив |
| Ábhair: | |
| Rochtain ar líne: | https://ter-arkhiv.ru/0040-3660/article/viewFile/637437/pdf |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
